CN104666992B - The Chinese medicine composition that hepatic and renal function caused by a kind of mitigation AIDS antiviral drugs damages - Google Patents
The Chinese medicine composition that hepatic and renal function caused by a kind of mitigation AIDS antiviral drugs damages Download PDFInfo
- Publication number
- CN104666992B CN104666992B CN201510056350.4A CN201510056350A CN104666992B CN 104666992 B CN104666992 B CN 104666992B CN 201510056350 A CN201510056350 A CN 201510056350A CN 104666992 B CN104666992 B CN 104666992B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- antiviral drugs
- aids antiviral
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000030507 AIDS Diseases 0.000 title claims abstract description 34
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 239000003443 antiviral agent Substances 0.000 title claims abstract description 29
- 230000006378 damage Effects 0.000 title claims abstract description 26
- 230000003907 kidney function Effects 0.000 title claims abstract description 24
- 230000003908 liver function Effects 0.000 title claims abstract description 24
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 230000000116 mitigating effect Effects 0.000 title abstract 3
- 210000004185 liver Anatomy 0.000 claims abstract description 33
- 244000197580 Poria cocos Species 0.000 claims abstract description 17
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 17
- 240000008042 Zea mays Species 0.000 claims abstract description 14
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 11
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 11
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 11
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 3
- 241001071795 Gentiana Species 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 14
- 241000092665 Atractylodes macrocephala Species 0.000 claims description 13
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 13
- 241001061264 Astragalus Species 0.000 claims description 12
- 235000007244 Zea mays Nutrition 0.000 claims description 12
- 235000006533 astragalus Nutrition 0.000 claims description 12
- 229940089639 cornsilk Drugs 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 12
- 210000004233 talus Anatomy 0.000 claims description 12
- 239000001231 zea mays silk Substances 0.000 claims description 12
- 244000236658 Paeonia lactiflora Species 0.000 claims description 11
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 11
- 240000005717 Dioscorea alata Species 0.000 claims description 10
- 235000002723 Dioscorea alata Nutrition 0.000 claims description 10
- 235000005362 Dioscorea floribunda Nutrition 0.000 claims description 9
- 235000004868 Dioscorea macrostachya Nutrition 0.000 claims description 9
- 235000005361 Dioscorea nummularia Nutrition 0.000 claims description 9
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 9
- 235000004879 dioscorea Nutrition 0.000 claims description 9
- 239000003826 tablet Substances 0.000 claims description 6
- 210000003734 kidney Anatomy 0.000 claims description 4
- 244000061520 Angelica archangelica Species 0.000 claims 5
- 208000001953 Hypotension Diseases 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 6
- 230000003394 haemopoietic effect Effects 0.000 abstract description 5
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract description 4
- 239000009636 Huang Qi Substances 0.000 abstract description 3
- 230000007812 deficiency Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract description 2
- 235000005822 corn Nutrition 0.000 abstract description 2
- 241000246500 Gentianella aspera Species 0.000 abstract 1
- 230000036770 blood supply Effects 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 208000012866 low blood pressure Diseases 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 239000000706 filtrate Substances 0.000 description 16
- 239000000284 extract Substances 0.000 description 14
- 210000004970 cd4 cell Anatomy 0.000 description 10
- 208000002173 dizziness Diseases 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 230000036772 blood pressure Effects 0.000 description 9
- 239000012141 concentrate Substances 0.000 description 9
- 241000125175 Angelica Species 0.000 description 8
- 239000004744 fabric Substances 0.000 description 8
- 230000036543 hypotension Effects 0.000 description 7
- 239000000546 pharmaceutical excipient Substances 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 230000000840 anti-viral effect Effects 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 230000035900 sweating Effects 0.000 description 6
- 206010067484 Adverse reaction Diseases 0.000 description 5
- 235000007056 Dioscorea composita Nutrition 0.000 description 5
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 5
- 230000006838 adverse reaction Effects 0.000 description 5
- 229940124531 pharmaceutical excipient Drugs 0.000 description 5
- 230000002269 spontaneous effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 208000016261 weight loss Diseases 0.000 description 4
- 230000004580 weight loss Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000008820 moutan cortex Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 241000132012 Atractylodes Species 0.000 description 2
- 206010019670 Hepatic function abnormal Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000002180 anti-stress Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 208000030208 low-grade fever Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 208000011726 slow pulse Diseases 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 235000002727 Dioscorea praehensilis Nutrition 0.000 description 1
- 235000002726 Dioscorea rotundata Nutrition 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000005807 Japanese encephalitis Diseases 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 238000011225 antiretroviral therapy Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 235000007183 paleface Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 208000026775 severe diarrhea Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【技术领域】【Technical field】
本发明涉及医药技术领域,特别涉及一种减轻艾滋病抗病毒药物引起的肝肾功能损伤的中药组合物。The invention relates to the technical field of medicine, in particular to a traditional Chinese medicine composition for alleviating liver and kidney function damage caused by AIDS antiviral drugs.
【技术领域】【Technical field】
艾滋病(HAART全称highly active antiretroviral therapy)是一种因病毒感染导致的免疫系统受损的疾病,艾滋病患者的不良反应与抗病毒治疗方案的选择相关,艾滋病患者多数不良反应发生于治疗后的第1个月内。抗病毒治疗后大多数患者CD4+T细胞计数都有所上升。目前仍无根治措施,但通过抗病毒治疗能有效延长患者的生存期,提高患者的生存质量,但是长期的抗病毒治疗会引起患者许多不良反应,如常见的消化道症状、神经肌肉系统不良反应,以及较严重的肝肾功能受损、骨髓抑制等,一旦出现不良反应将对实施抗病毒治疗的患者的依从性产生一定的影响。本发明采用的中药组合物对减轻艾滋病抗病毒药物引起的肝肾功能损伤,辨证施治、攻补兼施、标本兼治,并且在临床实验用于减轻艾滋病抗病毒药物引起的肝肾功能损伤病例中,取得显著的治疗效果,安全无毒副作用。AIDS (highly active antiretroviral therapy for HAART) is a disease of immune system damage caused by viral infection. The adverse reactions of AIDS patients are related to the choice of antiviral therapy. Most of the adverse reactions of AIDS patients occur in the first day after treatment. within a month. CD4+ T cell counts increased in most patients after antiviral treatment. At present, there is still no cure, but antiviral treatment can effectively prolong the survival period of patients and improve the quality of life of patients, but long-term antiviral treatment will cause many adverse reactions in patients, such as common gastrointestinal symptoms, neuromuscular system adverse reactions , as well as severe liver and kidney function impairment, bone marrow suppression, etc., once adverse reactions occur, it will have a certain impact on the compliance of patients receiving antiviral treatment. The traditional Chinese medicine composition adopted in the present invention can reduce the damage of liver and kidney function caused by AIDS antiviral drugs, treat according to syndrome differentiation, attack and complement, treat both symptoms and root causes, and is used in clinical trials to reduce the cases of liver and kidney function damage caused by AIDS antiviral drugs It has achieved remarkable therapeutic effects, is safe and has no side effects.
【发明内容】【Content of invention】
本发明的目的在于提供一种能够有效地减轻艾滋病抗病毒药物引起的肝肾功能损伤的中药组合物,本发明所提供的减轻艾滋病抗病毒药物引起的肝肾功能损伤的中药组合物可有效地治疗肝造血不足、低血压、脑供血不全、心绞痛等病症,能够有效地减轻艾滋病抗病毒药物引起的肝肾功能损伤,治疗速度快、疗效高、治疗成本低。The object of the present invention is to provide a kind of traditional Chinese medicine composition that can effectively alleviate the damage of liver and kidney function caused by AIDS antiviral drugs, and the traditional Chinese medicine composition for reducing the damage of liver and kidney function caused by AIDS antiviral drugs can effectively The treatment of hepatic hematopoietic insufficiency, hypotension, cerebral insufficiency, angina pectoris and other diseases can effectively alleviate the liver and kidney function damage caused by AIDS antiviral drugs, and the treatment speed is fast, the curative effect is high, and the treatment cost is low.
本发明的技术方案是:Technical scheme of the present invention is:
减轻艾滋病抗病毒药物引起的肝肾功能损伤的中药组合物,其主要原料和重量份数如下:牡丹皮15~25份、山药8~12份、茯苓20~30份、白术6~10份、龙胆15~25份、黄芪8~12份、当归14~18份、白芍6~10份、玉米须4~8份。The traditional Chinese medicine composition for alleviating liver and kidney function damage caused by AIDS antiviral drugs has the following main raw materials and parts by weight: 15-25 parts of Cortex Moutan, 8-12 parts of Chinese yam, 20-30 parts of Poria cocos, 6-10 parts of Atractylodes macrocephala, 15-25 parts of gentian, 8-12 parts of astragalus, 14-18 parts of angelica, 6-10 parts of white peony, and 4-8 parts of corn silk.
进一步地,减轻艾滋病抗病毒药物引起的肝肾功能损伤的中药组合物,其主要原料和重量份数如下:牡丹皮20份、山药10份、茯苓25份、白术8份、龙胆20份、黄芪10份、当归16份、白芍8份、玉米须6份。Further, the traditional Chinese medicine composition for reducing liver and kidney function damage caused by AIDS antiviral drugs has the following main raw materials and parts by weight: 20 parts of Moutan cortex, 10 parts of Chinese yam, 25 parts of Poria cocos, 8 parts of Atractylodes macrocephala, 20 parts of gentian, 10 parts of astragalus, 16 parts of angelica, 8 parts of white peony, and 6 parts of corn silk.
本发明的减轻艾滋病抗病毒药物引起的肝肾功能损伤的药物按相关剂型的常规制剂工艺,加入适量辅料制成相应的剂型,上述药物可以制成口服液、胶囊、片剂、颗粒剂或其它可药用的剂型。According to the conventional preparation process of related dosage forms, the medicine for alleviating liver and kidney function damage caused by AIDS antiviral drugs of the present invention is made into corresponding dosage forms by adding appropriate amount of auxiliary materials. The above-mentioned medicines can be made into oral liquid, capsules, tablets, granules or other Pharmaceutically acceptable dosage forms.
以上所述的减轻艾滋病抗病毒药物引起的肝肾功能损伤的口服液的生产方法,是按重量配比取牡丹皮、山药、茯苓、白术、龙胆、黄芪、当归、白芍、玉米须。按总量加水4-6倍煎煮三次,每次2小时,合并煎液,过滤、加入医学上认可的药用辅料,制成口服液。The production method of the above-mentioned oral liquid for reducing liver and kidney function damage caused by AIDS antiviral drugs is to take Moutan Cortex, Chinese Yam, Poria, Atractylodes Rhizoma Atractylodes Rhizome, Gentiana, Radix Astragali, Angelica, Radix Paeoniae Alba, and Corn Silk in proportion by weight. Add 4-6 times the total amount of water and decoct three times, each time for 2 hours, combine the decoction, filter, add medically approved pharmaceutical excipients, and make an oral liquid.
以上所述的减轻艾滋病抗病毒药物引起的肝肾功能损伤的制剂的生产方法,其特征在于:按重量配比取牡丹皮、山药、茯苓、白术、龙胆、黄芪、当归、白芍、玉米须,按总重量加水4-6倍煎煮三次,每次2小时,合并煎液,过滤、浓缩至相对密度为1.30~1.32的稠膏,再在80℃以下干燥,粉碎成细粉,加入辅料,混匀,制成胶囊、片剂或颗粒。The production method of the above-mentioned preparation for alleviating the liver and kidney function damage caused by AIDS antiviral drugs is characterized in that: Cortex Moutan, Chinese yam, Poria cocos, Atractylodes macrocephala, Gentiana, Radix Astragali, Angelica sinensis, Radix Paeoniae Alba, corn Add water 4-6 times according to the total weight and decoct three times, 2 hours each time, combine the decoction, filter and concentrate to a thick paste with a relative density of 1.30-1.32, then dry below 80°C, grind into fine powder, add Excipients, mixed well, made into capsules, tablets or granules.
本发明中的中药详细情况如下:Chinese medicine details among the present invention are as follows:
牡丹皮,清热、活血散瘀,主治热病、发斑、吐衄、热泪盈眶病菌后期热伏阴分发热、阴虚骨蒸潮热、血滞经闭、痛经、痈肿疮毒、跌扑伤痛、风湿热痹功效。Cortex Moutan, heat-clearing, promoting blood circulation and dissipating blood stasis, mainly treating febrile disease, spotting, spit bleed, hot tears filling the eyes, pathogenic bacteria in the later stage, hot volts, hot flashes, blood stagnation, amenorrhea, dysmenorrhea, carbuncle sores, fall Flutter pain, rheumatic heat arthralgia effect.
山药,山药又称薯蓣、土薯、山薯蓣、怀山药、淮山、白山药,有滋养强壮,助消化,敛虚汗,止泻之功效,主治脾虚腹泻、肺虚咳嗽、糖尿病消渴、小便短频、遗精、妇女带下及消化不良的慢性肠炎。Yam, also known as yam, yam, yam, Chinese yam, yam, and white yam, has nourishing and strong effects, helps digestion, suppresses sweating, and relieves diarrhea. Chronic enteritis with frequency, nocturnal emission, women's leukorrhagia and indigestion.
茯苓,俗称云苓、松苓、茯灵,为多孔菌茯苓,是一种干燥菌核,古人称茯苓为“四时神药”,因为它功效非常广泛,不分四季,将它与各种药物配伍,不管寒、温、风、湿诸疾,都能发挥其独特功效。茯苓性平,味甘、淡,具有利水渗湿、益脾和胃、宁心安神之功用。Poria cocos, commonly known as Yunling, Songling and Poria cocos, is a porous fungus Poria cocos. The combination of medicines can exert its unique effects regardless of cold, temperature, wind and damp diseases. Poria cocos is flat in nature, sweet and light in taste, and has the functions of diuresis and dampness, benefiting the spleen and stomach, calming the mind and calming the nerves.
白术,又名:冬白术,于术,冬术,具有调整胃肠运动功能,抗溃疡、保肝、增强机体免疫功能、抗应激、增强造血功能、抗氧化、延缓衰老、降血糖、抗凝血、抗肿瘤等功效。Atractylodes macrocephala, also known as: Dongbaizhu, Yuzhu, Dongzhu, has the functions of adjusting gastrointestinal motility, anti-ulcer, protecting the liver, enhancing the immune function of the body, anti-stress, enhancing hematopoietic function, anti-oxidation, delaying aging, lowering blood sugar, anti-aging Coagulation, anti-tumor and other effects.
当归,性温,味甘辛。归心、肝、脾经。补血和血,调经止痛,润燥滑肠。治月经不调,经闭腹痛,症瘕结聚,崩漏,血虚头痛,眩晕,痿痹;肠燥便难,赤痢后重;痈疽疮窃,跌扑损伤。Angelica, warm in nature, sweet and pungent in taste. GUIXIN, liver, spleen channel. Enrich blood and blood, regulate menstruation and relieve pain, moisten dryness and smooth intestines. Control irregular menstruation, amenorrhea abdominal pain, mass in the abdomen, metrorrhagia, blood deficiency headache, dizziness, impotence; dryness of the intestines, difficulty in defecation, severe diarrhea after redness; carbuncle sores, injuries from falls.
黄芪,能增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。能消除实验性肾炎蛋白尿,增强心肌收缩力,调节血糖含量。Astragalus can enhance the immune function of the body, protect the liver, diuretic, anti-aging, anti-stress, lower blood pressure and have a wide range of antibacterial effects. It can eliminate experimental nephritis proteinuria, enhance myocardial contractility, and regulate blood sugar levels.
龙胆,泻肝胆实火,除下焦湿热。治肝经热盛,惊痫狂躁,乙型脑炎,头痛,目赤,咽痛,黄疸,热痢,痈肿疮疡,阴囊肿痛,阴部湿痒。用于湿热黄疽、阴肿阴痒、带下、湿疹瘙痒、耳聋、胁痛、口苦、惊风抽搐。Gentiana, purging liver and gallbladder excess fire, removes damp-heat in lower burnt. Control excessive heat in the liver meridian, convulsions, epilepsy and mania, Japanese encephalitis, headache, red eyes, sore throat, jaundice, dysentery, carbuncle sores, swollen and painful scrotum, and wet itching in the genitals. For damp heat jaundice, pruritus vulvae, vaginal discharge, eczema itching, deafness, hypochondriac pain, bitter mouth, convulsions and convulsions.
白芍,性凉、味苦酸,微寒,具有补血养血、平抑肝阳、柔肝止痛、敛阴止汗等功效,适用于阴虚发热、月经不调、胸腹胁肋疼痛、四肢挛急,泻痢腹痛、自汗盗汗、崩漏、带下等症。Radix Paeoniae Alba, cool in nature, bitter in taste, slightly cold, has the functions of nourishing blood and nourishing blood, calming liver yang, softening liver and relieving pain, astringing yin and antiperspirant, etc. Convulsions, dysentery, abdominal pain, spontaneous sweating, metrorrhagia, leukorrhea embolism.
玉米须,性平,味甘淡,无毒。入肝、肾、膀胱经。利尿,泄热,平肝,利胆。治肾炎水肿,脚气,黄疸肝炎,高血压,胆囊炎,胆结石,糖尿病,吐血衄血,鼻渊,乳痈。Corn silk, flat in nature, sweet and light in taste, non-toxic. Go into liver, kidney, urinary bladder channel. Diuretic, expel heat, calm the liver, promote choleresis. Control nephritis edema, beriberi, jaundice hepatitis, hypertension, cholecystitis, gallstones, diabetes, hematemesis and epistaxis, nasal sinusitis, mastitis.
本发明采用以上技术方案,与现有技术相比,具有以下优点:本发明药物的产品用于治疗肝造血不足、低血压、脑供血不全、心绞痛等病症,能够有效地减轻艾滋病抗病毒药物引起的肝肾功能损伤,治疗速度快、疗效高、治疗成本低等优点。The present invention adopts the above technical scheme, and compared with the prior art, it has the following advantages: the product of the medicine of the present invention is used to treat diseases such as hepatic hematopoietic insufficiency, hypotension, cerebral insufficiency, angina pectoris, etc., and can effectively alleviate the symptoms caused by AIDS antiviral drugs. It has the advantages of fast treatment speed, high curative effect and low treatment cost.
下面结合具体实施方式对本发明的技术方案做进一步的说明。The technical solutions of the present invention will be further described below in conjunction with specific embodiments.
【具体实施方式】【Detailed ways】
实施例1Example 1
一种减轻艾滋病抗病毒药物引起的肝肾功能损伤的中药组合物,由以下组分按照重量分类组成(每份1g);A traditional Chinese medicine composition for alleviating liver and kidney function damage caused by AIDS antiviral drugs, which is composed of the following components classified by weight (1g per part);
牡丹皮15份、山药8份、茯苓20份、白术6份、龙胆15份、黄芪8份、当归14份、白芍6份、玉米须4份,按以上成分及配比,煎煮法提取三次,首次按料液比为1:8加水,浸泡30min,煮沸提取30min,300目滤布过滤,滤液备用;药渣按料液比为1:6加水,煮沸提取30min,300目滤布过滤,滤液备用;药渣按料液比为1:4加水,煮沸提取30min,300目滤布过滤,合并三次滤液,浓缩至1:1,静置48h,过滤,滤液浓缩至相对密度为1.15,即得到原料的提取物,再加入药用辅料稀释制成口服液。15 parts of Moutan cortex, 8 parts of Chinese yam, 20 parts of Poria cocos, 6 parts of Atractylodes macrocephala, 15 parts of gentian, 8 parts of astragalus, 14 parts of angelica, 6 parts of white peony, 4 parts of corn silk, according to the above ingredients and proportions, decocting method Extract three times, first add water according to the material-liquid ratio of 1:8, soak for 30 minutes, boil for extraction for 30 minutes, filter with a 300-mesh filter cloth, and use the filtrate for later use; Filter the filtrate for later use; add water to the dregs according to the material-to-liquid ratio of 1:4, boil and extract for 30 minutes, filter through a 300-mesh filter cloth, combine the filtrate three times, concentrate to 1:1, let stand for 48 hours, filter, and concentrate the filtrate to a relative density of 1.15 , that is to obtain the extract of the raw material, and then add pharmaceutical excipients to dilute to make an oral liquid.
实施例2Example 2
一种减轻艾滋病抗病毒药物引起的肝肾功能损伤的中药组合物,由以下组分按照重量分类组成(每份1g);A traditional Chinese medicine composition for alleviating liver and kidney function damage caused by AIDS antiviral drugs, which is composed of the following components classified by weight (1g per part);
牡丹皮20份、山药10份、茯苓25份、白术8份、龙胆20份、黄芪10份、当归14份、白芍8份、玉米须6份,按以上成分及配比,煎煮法提取三次,首次按料液比为1:8加水,浸泡30min,煮沸提取30min,300目滤布过滤,滤液备用;药渣按料液比为1:6加水,煮沸提取30min,300目滤布过滤,滤液备用;药渣按料液比为1:4加水,煮沸提取30min,300目滤布过滤,合并三次滤液,浓缩至1:1,静置48h,过滤,滤液浓缩至相对密度为1.15,即得到原料的提取物,再加入药用辅料PEG4000和糊精,用水或者淀粉浆使之粘合,用干法制粒机直接制粒或湿法制粒后干燥,粉碎,加辅料制粒,装入胶囊壳,得到胶囊。20 parts of Moutan bark, 10 parts of Chinese yam, 25 parts of Poria cocos, 8 parts of Atractylodes macrocephala, 20 parts of gentian, 10 parts of astragalus, 14 parts of angelica, 8 parts of white peony, 6 parts of corn silk, according to the above ingredients and proportions, decocting method Extract three times, first add water according to the material-liquid ratio of 1:8, soak for 30 minutes, boil for extraction for 30 minutes, filter with a 300-mesh filter cloth, and use the filtrate for later use; Filter the filtrate for later use; add water to the dregs according to the material-to-liquid ratio of 1:4, boil and extract for 30 minutes, filter through a 300-mesh filter cloth, combine the filtrate three times, concentrate to 1:1, let stand for 48 hours, filter, and concentrate the filtrate to a relative density of 1.15 , that is to obtain the extract of the raw material, then add pharmaceutical excipients PEG4000 and dextrin, make it bonded with water or starch slurry, dry it directly with a dry granulator or wet granulate, then dry, crush, add excipients to granulate, pack into the capsule shell to obtain a capsule.
实施例3Example 3
一种减轻艾滋病抗病毒药物引起的肝肾功能损伤的中药组合物,由以下组分按照重量分类组成(每份1g);A traditional Chinese medicine composition for alleviating liver and kidney function damage caused by AIDS antiviral drugs, which is composed of the following components classified by weight (1g per part);
牡丹皮25份、山药12份、茯苓30份、白术10份、龙胆25份、黄芪12份、当归16份、白芍10份、玉米须8份,按以上成分及配比,煎煮法提取三次,首次按料液比为1:8加水,浸泡30min,煮沸提取30min,300目滤布过滤,滤液备用;药渣按料液比为1:6加水,煮沸提取30min,300目滤布过滤,滤液备用;药渣按料液比为1:4加水,煮沸提取30min,300目滤布过滤,合并三次滤液,浓缩至1:1,静置48h,过滤,滤液浓缩至相对密度为1.15,即得到原料的提取物,向上述制备得到的原料提取物中加入药用辅料乳糖、PEG4000、硬脂酸镁,用水或者淀粉浆使之粘合,用干法制粒机直接制粒或湿法制粒后干燥,制粒,用压片机压片即得片剂。25 parts of Moutan bark, 12 parts of Chinese yam, 30 parts of Poria cocos, 10 parts of Atractylodes macrocephala, 25 parts of gentian, 12 parts of astragalus, 16 parts of angelica, 10 parts of white peony, and 8 parts of corn silk. Extract three times, first add water according to the material-liquid ratio of 1:8, soak for 30 minutes, boil for extraction for 30 minutes, filter with a 300-mesh filter cloth, and use the filtrate for later use; Filter the filtrate for later use; add water to the dregs according to the material-to-liquid ratio of 1:4, boil and extract for 30 minutes, filter through a 300-mesh filter cloth, combine the filtrate three times, concentrate to 1:1, let stand for 48 hours, filter, and concentrate the filtrate to a relative density of 1.15 , that is to obtain the extract of the raw material, add pharmaceutical excipients lactose, PEG4000, magnesium stearate to the raw material extract prepared above, bind it with water or starch slurry, and directly granulate it with a dry granulator or wet process After granulation, dry, granulate, and compress with a tablet machine to obtain tablets.
实施例4Example 4
一种减轻艾滋病抗病毒药物引起的肝肾功能损伤的中药组合物,由以下组分按照重量分类组成(每份1g);A traditional Chinese medicine composition for alleviating liver and kidney function damage caused by AIDS antiviral drugs, which is composed of the following components classified by weight (1g per part);
牡丹皮25份、山药12份、茯苓30份、白术10份、龙胆25份、黄芪12份、当归16份、白芍10份、玉米须8份,按以上成分及配比,煎煮法提取三次,首次按料液比为1:8加水,浸泡30min,煮沸提取30min,300目滤布过滤,滤液备用;药渣按料液比为1:6加水,煮沸提取30min,300目滤布过滤,滤液备用;药渣按料液比为1:4加水,煮沸提取30min,300目滤布过滤,合并三次滤液,浓缩至1:1,静置48h,过滤,滤液浓缩至相对密度为1.15,即得到原料的提取物,向上述制备得到的原料提取物中加入药用辅料羧甲基淀粉钠,用水使之粘合,用干法制粒机直接制粒或湿法制粒后干燥、整粒,分装,即得颗粒剂。25 parts of Moutan bark, 12 parts of Chinese yam, 30 parts of Poria cocos, 10 parts of Atractylodes macrocephala, 25 parts of gentian, 12 parts of astragalus, 16 parts of angelica, 10 parts of white peony, and 8 parts of corn silk. Extract three times, first add water according to the material-liquid ratio of 1:8, soak for 30 minutes, boil for extraction for 30 minutes, filter with a 300-mesh filter cloth, and use the filtrate for later use; Filter the filtrate for later use; add water to the dregs according to the material-to-liquid ratio of 1:4, boil and extract for 30 minutes, filter through a 300-mesh filter cloth, combine the filtrate three times, concentrate to 1:1, let stand for 48 hours, filter, and concentrate the filtrate to a relative density of 1.15 , that is to obtain the extract of the raw material, add the pharmaceutical excipient sodium carboxymethyl starch to the raw material extract prepared above, make it stick with water, use a dry granulator to directly granulate or wet granulate, then dry and granulate , subpackaged to obtain granules.
病例1Case 1
艾滋病感染者丘某某,广西玉林市人,于2010年出现持续低烧不退、头晕恶心等症状,2011年于广西玉林市人民医院检查血液,初复筛HIV阳性,后经确证实验确诊为HIV感染者。2012年开始接受鸡尾酒疗法,当时测CD4细胞计数为531,体重60kg,后经艾滋病抗病毒药物治疗,2013年1月开始出现头晕、低血压(血压值60/51mmhg)、面黄无血色,精神极差,消瘦、乏力、自汗、易感冒,平均每月10次,腹泻,平均每天5次,水样便,时有畏寒,反酸,吐清水,脉沉无力,舌淡苔白,自服止泻药,未见好转,遂来医院就诊,测CD4细胞计数为301,体重48kg,中医诊为泄泻,脾肾阳虚,肝脏功能受损,服用本发明实施例1的口服液,每天三次,每次20ml,2014年5月,测CD4细胞计数为526,头晕、头痛现象消失,测量血压值(90/80mmhg),精神饱满。AIDS-infected person Qiu Moumou, from Yulin City, Guangxi, had symptoms such as persistent low-grade fever, dizziness, and nausea in 2010. In 2011, he had a blood test at the People’s Hospital of Yulin City, Guangxi. He was positive for HIV in the initial screening and was later confirmed to be HIV by a confirmatory test. infected. He began to receive cocktail therapy in 2012. At that time, the CD4 cell count was 531 and his weight was 60kg. After being treated with AIDS antiviral drugs, he began to experience dizziness, hypotension (blood pressure 60/51mmhg), pale face, and spirit in January 2013. Extremely poor, weight loss, fatigue, spontaneous sweating, easy to catch a cold, an average of 10 times a month, diarrhea, an average of 5 times a day, watery stools, chills from time to time, acid regurgitation, clear water spit, deep and weak pulse, pale tongue with white coating, Self-service antidiarrheal medicine, no improvement, then come to the hospital for medical treatment, measuring CD4 cell count is 301, body weight 48kg, Chinese medicine diagnosis is diarrhea, spleen and kidney yang deficiency, impaired liver function, taking the oral liquid of the embodiment of the present invention 1, Three times a day, 20ml each time, in May 2014, the CD4 cell count was 526, the dizziness and headache disappeared, the blood pressure (90/80mmhg) was measured, and the spirit was full.
病例2Case 2
艾滋病感染者江某某,贵港市港北区人,有吸毒经验经历,曾频繁使用注射器吸毒,并曾多次与他人共用注射器,2012年初因高热住院时初筛HIV阳性,后经实验确诊为HIV感染。当时CD4细胞计数为576,后经艾滋病抗病毒药物治疗,2013年1月份开始出现身体乏力、消瘦,自汗、易感、冒头晕、低血压(血压值64/50mmhg)、面黄无血色,精神极差,时有畏寒,时有反酸,吐清水,脉沉迟无力,舌淡苔白,自服西药,未见好转,遂来我中心就诊,测CD4细胞计数为212,中医诊为阳痿,脾肾阳虚,肝脏功能受损,服用本发明实施例2的胶囊,每天三次,每次三粒,2014年3月,测CD4细胞计数为423,头晕、头痛现象消失,测量血压值(95/68mmhg),精神饱满。Jiang Moumou, an HIV-infected person from Gangbei District, Guigang City, has experience in drug abuse, frequently used syringes to take drugs, and shared syringes with others many times. In early 2012, he was initially screened positive for HIV when he was hospitalized due to high fever, and was later confirmed HIV positive by experiment. Infect. At that time, the CD4 cell count was 576. After being treated with AIDS antiviral drugs, in January 2013, he began to experience physical fatigue, weight loss, spontaneous sweating, susceptibility, dizziness, hypotension (blood pressure 64/50mmhg), yellow and pale complexion, The spirit is extremely poor, sometimes chills, sometimes acid regurgitation, spit clear water, slow and weak pulse, pale tongue with white coating, self-administration of western medicine, but no improvement, so I came to our center for treatment, and the CD4 cell count was 212. For impotence, deficiency of spleen and kidney yang, and impaired liver function, take the capsule of Example 2 of the present invention, three times a day, three capsules each time, in March 2014, the CD4 cell count was 423, dizziness and headache disappeared, and the blood pressure was measured Value (95/68mmhg), full of energy.
病例3Case 3
艾滋病感染者叶某,农民,广西横县人,于2010年发现为HIV阳性,2012年3月因高烧不退住院后经广西区CDC确诊为HIV感染者。当时测CD4细胞计数为511,后经艾滋病抗病毒药物治疗,2013年4月开始出现消瘦,乏力,自汗、易感冒、头晕、低血压(血压值71/56mmhg)、面黄无血色,时有反酸,吐清水,脉沉迟无力,舌淡苔白,自服用西药,未见好转。经就诊我中心,开处方为本发明实施例3片剂,每天三次,每次三粒,每粒约1.2g,测CD4细胞计数为433,头晕、头痛现象消失,测量血压值(93/71mmhg),精神饱满。An HIV-infected patient named Ye, a farmer, from Heng County, Guangxi, was found to be HIV-positive in 2010. After being hospitalized due to persistent high fever in March 2012, he was diagnosed as an HIV-infected person by the Guangxi CDC. At that time, the CD4 cell count was 511, and after treatment with AIDS antiviral drugs, she began to suffer from weight loss, fatigue, spontaneous sweating, colds, dizziness, hypotension (blood pressure 71/56mmhg), yellowish and pale complexion in April 2013. Have acid reflux, spit clear water, deep and slow pulse, pale tongue with white fur, self-administration of western medicine, no improvement. Through visiting our center, prescription is the embodiment of the present invention 3 tablets, every day three times, each three, every about 1.2g, measure CD4 cell count and be 433, dizziness, headache disappear, measure blood pressure value (93/71mmhg ), full of energy.
病例4Case 4
艾滋病感染者周某,广西来宾市人,于2012年经常低烧不退,入院检查发现为HIV阳性,经广西区CDC确诊为HIV感染者。当时测CD4细胞计数为456,后经艾滋病抗病毒药物治疗,2013年10月分开始出现消瘦,乏力,自汗、易感、冒头晕、低血压(血压值71/56mmhg)、面黄无血色,时有反酸,吐清水,脉沉迟无力,舌淡苔白。2013年11月来我中心就诊开处方为本发明的实施例4的颗粒,每天三次,每次三粒,每粒约为1.2g,2014年12月,测得CD4细胞计数为411,头晕、头痛现象消失,测量血压值(90/65mmhg),精神饱满。An HIV-infected person named Zhou, from Laibin City, Guangxi, had a low-grade fever that persisted in 2012. He was found to be HIV-positive upon admission to the hospital, and was diagnosed as an HIV-infected person by the Guangxi District CDC. At that time, the CD4 cell count was 456, and after treatment with AIDS antiviral drugs, in October 2013, he began to experience weight loss, fatigue, spontaneous sweating, susceptibility, dizziness, hypotension (blood pressure 71/56mmhg), yellow and pale complexion , acid regurgitation from time to time, spit clear water, deep and slow pulse, pale tongue with white fur. In November 2013, I came to our center to see a doctor and prescribed the granules of Example 4 of the present invention, three times a day, three capsules each time, each capsule was about 1.2g, and in December 2014, the CD4 cell count was 411, dizziness, The headache disappears, the blood pressure (90/65mmhg) is measured, and the spirit is full.
临床结论clinical conclusion
临床结果表明,本发明的中药与艾滋病抗病毒联合应用6个月后,HIV感染者的肝造血不足、低血压、脑供血不全、心绞痛等症状得到了有效的减轻。说明本发明的中药能够减轻艾滋病抗病毒药物引起的肝肾功能损伤。The clinical results show that after 6 months of combined application of the traditional Chinese medicine and AIDS antiviral, the symptoms of HIV-infected patients such as liver hematopoietic insufficiency, hypotension, cerebral insufficiency, and angina pectoris have been effectively alleviated. It shows that the traditional Chinese medicine of the present invention can alleviate the liver and kidney function damage caused by AIDS antiviral drugs.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510056350.4A CN104666992B (en) | 2015-02-03 | 2015-02-03 | The Chinese medicine composition that hepatic and renal function caused by a kind of mitigation AIDS antiviral drugs damages |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510056350.4A CN104666992B (en) | 2015-02-03 | 2015-02-03 | The Chinese medicine composition that hepatic and renal function caused by a kind of mitigation AIDS antiviral drugs damages |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104666992A CN104666992A (en) | 2015-06-03 |
CN104666992B true CN104666992B (en) | 2018-06-08 |
Family
ID=53302928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510056350.4A Expired - Fee Related CN104666992B (en) | 2015-02-03 | 2015-02-03 | The Chinese medicine composition that hepatic and renal function caused by a kind of mitigation AIDS antiviral drugs damages |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104666992B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111617161A (en) * | 2020-05-25 | 2020-09-04 | 云南省中医中药研究院 | Traditional Chinese medicine composition for relieving liver and kidney injury caused by AIDS (acquired immune deficiency syndrome) antiviral drugs |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
CN101647563A (en) * | 2009-09-04 | 2010-02-17 | 马鞍山神鹿科瑞药业有限公司 | Compound black-bone chicken honeyed pill and preparation method thereof |
CN102293288A (en) * | 2011-06-21 | 2011-12-28 | 山西大学 | Healthy tea for conditioning of qi stagnation and blood stasis-type physique, and manufacturing method thereof |
-
2015
- 2015-02-03 CN CN201510056350.4A patent/CN104666992B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
CN101647563A (en) * | 2009-09-04 | 2010-02-17 | 马鞍山神鹿科瑞药业有限公司 | Compound black-bone chicken honeyed pill and preparation method thereof |
CN102293288A (en) * | 2011-06-21 | 2011-12-28 | 山西大学 | Healthy tea for conditioning of qi stagnation and blood stasis-type physique, and manufacturing method thereof |
Non-Patent Citations (2)
Title |
---|
中西医结合治疗艾滋病抗病毒治疗后肝损伤疗效观察;熊卫标等;《实用中西医结合临床》;20110925;第11卷(第5期);第59页"1.3治疗方法" * |
爱康胶囊对HIV/AIDS患者生存质量的影响;谢世平等;《上海中医药杂志》;20070930;第41卷(第9期);第15页右栏"1.1.2中医辨证标准",第16页左栏"1.3治疗方法",第18页左栏倒数第2段 * |
Also Published As
Publication number | Publication date |
---|---|
CN104666992A (en) | 2015-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105920514A (en) | Traditional Chinese medicinal composition for treating metabolic syndrome | |
CN100496585C (en) | Chloasma treating Chinese medicine preparation | |
CN104383433A (en) | Traditional Chinese medicine preparation for treating scanty menstruation | |
CN102526498A (en) | Chinese medicine for eliminating toxic and side effects after nasopharyngeal carcinoma radiotherapy and preparation method and administration way thereof | |
CN108619355A (en) | A kind of antitumor Chinese and preparation method thereof | |
CN104666992B (en) | The Chinese medicine composition that hepatic and renal function caused by a kind of mitigation AIDS antiviral drugs damages | |
CN109602817B (en) | A traditional Chinese medicine composition for treating osteoporosis caused by estrogen reduction | |
CN115282229B (en) | Traditional Chinese medicine composition for treating qi deficiency and blood stasis type coronary heart disease and preparation method thereof | |
CN103520571B (en) | Traditional Chinese medicine for treating qi stagnation and blood stasis syndrome type abdominal mass diseases | |
CN102343019B (en) | Chinese medicinal composition for treating amenorrhea and preparation method of preparation thereof | |
CN102416145A (en) | Traditional Chinese medicine composition for treating menstrual disorder | |
CN101983695A (en) | Traditional Chinese medicine composition for curing hemiplegia and preparation method thereof | |
CN104383155A (en) | Chinese medicinal composition for treating constipation | |
CN104147388A (en) | Traditional Chinese medicine composition for treating migraine and preparation method thereof | |
CN106420970A (en) | Pharmaceutical composition for curing premature ovarian failure | |
CN105434541A (en) | Antidote for treating herpes zoster | |
CN104547700B (en) | A traditional Chinese medicine composition for treating early menstruation | |
CN105796927B (en) | A kind of Chinese medicine composition for treating blepharospasm | |
CN104258037A (en) | Traditional Chinese medicine composition for treating lung cancer and preparation method thereof | |
CN103908563A (en) | Traditional Chinese medicine medicament for treating extraskeletal osteosarcoma and preparation method thereof | |
CN104116805A (en) | Traditional Chinese medicinal preparation for treating pelvic congestion syndrome | |
CN114886966B (en) | A traditional Chinese medicine composition for relieving side effects of sunitinib and its preparation method and application | |
CN103446561A (en) | Stasis-dissipating soup formula | |
CN105641425A (en) | Traditional Chinese medicine composition for treating night sweat due to yin deficiency and preparation method thereof | |
CN120189463A (en) | Traditional Chinese medicine composition for treating chronic kidney diseases and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180608 |